Juan-Jose Ventura
Research Subjects
Juan-Jose Ventura has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Richard A. Flavell
Howard Hughes Medical Institute and Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520
7 shared publications- César Roncero
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, E-28040 Madrid, Spain
5 shared publications Feride Oeztuerk-Winder
Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom
5 shared publications- Isabel Fabregat
National Biomedical Research Institute on Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; TGF-β and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
5 shared publications Roger J. Davis
4 shared publications- Roger J. Davis
Program in Molecular Medicine, University of Massachusetts Chan Medical School, Massachusetts, USA
4 shared publications
Latest Publications
- Open Access
- 10 September 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11, e64954
Exploring Women’s Perceptions of Traditional Mammography and the Concept of AI-Driven Thermography to Improve the Breast Cancer Screening Journey: Mixed Methods Study
Background: Breast cancer is the most common cancer among women and a leading cause of mortality in Europe. Early detection through screening reduces mortality, yet participation in mammography-based programs remains suboptimal due to discomfort, radiation exposure, and accessibility issues. Thermography, particularly when driven by artificial intelligence (AI), is being explored as a noninvasive, radiation-free alternative. However, its acceptance, reliability, and impact on the screening experience remain underexplored. Objective: This study aimed to explore women’s perceptions of AI-enhanced thermography (ThermoBreast) as an alternative to mammography. It aims to identify barriers and motivators related to breast cancer screening and assess how ThermoBreast might improve the screening experience. Methods: A mixed methods approach was adopted, combining an online survey with follow-up focus groups. The survey captured women’s knowledge, attitudes, and experiences related to breast cancer screening and was used to recruit participants for qualitative exploration. After the focus groups, the survey was relaunched to include additional respondents. Quantitative data were analyzed using SPSS (IBM Corp), and qualitative data were analyzed in MAXQDA (VERBI software). Findings from both strands were synthesized to redesign the breast cancer screening journey. Results: A total of 228 valid survey responses were analyzed. Of 228, 154 women (68%) had previously undergone mammography, while 74 (32%) had not. The most reported motivators were belief in prevention (69/154, 45%), invitations from screening programs (68/154, 44%), and doctor recommendations (45/154, 29%). Among nonscreeners, key barriers included no recommendation from a doctor (39/74, 53%), absence of symptoms (27/74, 36%), and perceived age ineligibility (17/74, 23%). Pain, long appointment waits, and fear of radiation were also mentioned. In total, 18 women (mean age 45.3 years, SD 13.6) participated in 6 focus groups. Participants emphasized the importance of respectful and empathetic interactions with medical staff, clear communication, and emotional comfort—factors they perceived as more influential than the screening technology itself. ThermoBreast was positively received for being contactless, radiation-free, and potentially more comfortable. Participants described it as “less traumatic,” “easier,” and “a game changer.” However, concerns were raised regarding its novelty, lack of clinical validation, and data privacy. Some participants expressed the need for human oversight in AI-supported procedures and requested more information on how AI is used. Based on these insights, an updated screening journey was developed, highlighting improvements in preparation, appointment booking, privacy, and communication of results. Conclusions: While AI-driven thermography shows promise as a noninvasive, user-friendly alternative to mammography, its adoption depends on trust, clinical validation, and effective communication from health care professionals. It may expand screening access for populations underserved by mammography, such as younger and immobile women, but does not eliminate all participation barriers. Long-term studies and direct comparisons between mammography and thermography are needed to assess diagnostic accuracy, patient experience, and their impact on screening participation and outcomes.
- 10 September 2025
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 11, e64954
Open AccessExploring Women’s Perceptions of Traditional Mammography and the Concept of AI-Driven Thermography to Improve the Breast Cancer Screening Journey: Mixed Methods Study
Background: Breast cancer is the most common cancer among women and a leading cause of mortality in Europe. Early detection through screening reduces mortality, yet participation in mammography-based programs remains suboptimal due to discomfort, radiation exposure, and accessibility issues. Thermography, particularly when driven by artificial intelligence (AI), is being explored as a noninvasive, radiation-free alternative. However, its acceptance, reliability, and impact on the screening experience remain underexplored. Objective: This study aimed to explore women’s perceptions of AI-enhanced thermography (ThermoBreast) as an alternative to mammography. It aims to identify barriers and motivators related to breast cancer screening and assess how ThermoBreast might improve the screening experience. Methods: A mixed methods approach was adopted, combining an online survey with follow-up focus groups. The survey captured women’s knowledge, attitudes, and experiences related to breast cancer screening and was used to recruit participants for qualitative exploration. After the focus groups, the survey was relaunched to include additional respondents. Quantitative data were analyzed using SPSS (IBM Corp), and qualitative data were analyzed in MAXQDA (VERBI software). Findings from both strands were synthesized to redesign the breast cancer screening journey. Results: A total of 228 valid survey responses were analyzed. Of 228, 154 women (68%) had previously undergone mammography, while 74 (32%) had not. The most reported motivators were belief in prevention (69/154, 45%), invitations from screening programs (68/154, 44%), and doctor recommendations (45/154, 29%). Among nonscreeners, key barriers included no recommendation from a doctor (39/74, 53%), absence of symptoms (27/74, 36%), and perceived age ineligibility (17/74, 23%). Pain, long appointment waits, and fear of radiation were also mentioned. In total, 18 women (mean age 45.3 years, SD 13.6) participated in 6 focus groups. Participants emphasized the importance of respectful and empathetic interactions with medical staff, clear communication, and emotional comfort—factors they perceived as more influential than the screening technology itself. ThermoBreast was positively received for being contactless, radiation-free, and potentially more comfortable. Participants described it as “less traumatic,” “easier,” and “a game changer.” However, concerns were raised regarding its novelty, lack of clinical validation, and data privacy. Some participants expressed the need for human oversight in AI-supported procedures and requested more information on how AI is used. Based on these insights, an updated screening journey was developed, highlighting improvements in preparation, appointment booking, privacy, and communication of results. Conclusions: While AI-driven thermography shows promise as a noninvasive, user-friendly alternative to mammography, its adoption depends on trust, clinical validation, and effective communication from health care professionals. It may expand screening access for populations underserved by mammography, such as younger and immobile women, but does not eliminate all participation barriers. Long-term studies and direct comparisons between mammography and thermography are needed to assess diagnostic accuracy, patient experience, and their impact on screening participation and outcomes.
- Open Access
- 1 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Enhancing the Breast Cancer Screening Journey: Exploring Women's Perceptions of Traditional Mammography and Emerging AI driven Thermography (Preprint)
BACKGROUND Breast cancer is one of the most frequent causes of mortality among women’s population. Early diagnosis is critical for successful treatment, but underscreening is frequent. Novel screening methods that are more convenient, such as thermography, are being developed. They could help a wider group of screeners and they could contribute to better compliance with screening and thus to a decline in breast cancer mortality. OBJECTIVE The study aims to explore the screeners’ preferences for the screening process, specifically for a novel screening that utilizes artificial intelligence (AI) and thermal imaging. Furthermore, we explore a better understanding of the barriers and facilitators associated with participation in breast cancer screening by currently used mammography. METHODS One online focus group with experts and five focus groups with potential screeners on thermography were carried out. Potential screeners were recruited through an online survey (n=228) focused on addressing barriers and motivations related to screening. Survey data were analyzed using SPSS software. Findings from the focus groups were examined by two researchers utilizing open, axial, and selective coding in MAXQDA software. RESULTS The information obtained in the focus groups showed that small changes during the procedure (tailored adjustments, such as film or music during the procedure, dimmed light) were appreciated, especially by women without any mammography screening experience. Furthermore, the non-invasiveness of the procedure was seen positively by all participants. Among other important factors that influence the perception of the procedure and can therefore affect the decision whether to go or not, was the way they were treated by medical staff and waiting hours. For certain women, how the interaction goes between them, and the clinicians is more important than the technology itself. Results from the online survey complemented these insights on motivation and barriers. Personal belief in breast cancer prevention was the most indicated motivator for women with mammography experience (44%, n=154), followed by an invitation from a screening program (29%, n=154). Barriers indicated by women without experience were mainly: no recommendation from a doctor (53%, n=74), no warning signals (36%, n=74) or no problem related to breasts (28%, n=74) followed by being too young for mammography (23%, n=74). CONCLUSIONS Even though the thermography was perceived mainly positively, rather than the technique itself, women prioritized how they were treated by medical staff. This includes detailed information in understandable language, empathetic communication and adjustments that fit personal preferences. As we also saw in the results from the survey, doctors play the leading role in the decision to go to the screening, so their change in the approach can encourage greater participation in breast cancer screening initiatives.
- 1 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEnhancing the Breast Cancer Screening Journey: Exploring Women's Perceptions of Traditional Mammography and Emerging AI driven Thermography (Preprint)
BACKGROUND Breast cancer is one of the most frequent causes of mortality among women’s population. Early diagnosis is critical for successful treatment, but underscreening is frequent. Novel screening methods that are more convenient, such as thermography, are being developed. They could help a wider group of screeners and they could contribute to better compliance with screening and thus to a decline in breast cancer mortality. OBJECTIVE The study aims to explore the screeners’ preferences for the screening process, specifically for a novel screening that utilizes artificial intelligence (AI) and thermal imaging. Furthermore, we explore a better understanding of the barriers and facilitators associated with participation in breast cancer screening by currently used mammography. METHODS One online focus group with experts and five focus groups with potential screeners on thermography were carried out. Potential screeners were recruited through an online survey (n=228) focused on addressing barriers and motivations related to screening. Survey data were analyzed using SPSS software. Findings from the focus groups were examined by two researchers utilizing open, axial, and selective coding in MAXQDA software. RESULTS The information obtained in the focus groups showed that small changes during the procedure (tailored adjustments, such as film or music during the procedure, dimmed light) were appreciated, especially by women without any mammography screening experience. Furthermore, the non-invasiveness of the procedure was seen positively by all participants. Among other important factors that influence the perception of the procedure and can therefore affect the decision whether to go or not, was the way they were treated by medical staff and waiting hours. For certain women, how the interaction goes between them, and the clinicians is more important than the technology itself. Results from the online survey complemented these insights on motivation and barriers. Personal belief in breast cancer prevention was the most indicated motivator for women with mammography experience (44%, n=154), followed by an invitation from a screening program (29%, n=154). Barriers indicated by women without experience were mainly: no recommendation from a doctor (53%, n=74), no warning signals (36%, n=74) or no problem related to breasts (28%, n=74) followed by being too young for mammography (23%, n=74). CONCLUSIONS Even though the thermography was perceived mainly positively, rather than the technique itself, women prioritized how they were treated by medical staff. This includes detailed information in understandable language, empathetic communication and adjustments that fit personal preferences. As we also saw in the results from the survey, doctors play the leading role in the decision to go to the screening, so their change in the approach can encourage greater participation in breast cancer screening initiatives.
- Open Access
Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases
Chronic lung diseases (CLDs) represent a set of disorders characterized by the progressive loss of proper lung function. Among severe CLDs, the incidence of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) has grown over the last decades, mainly in the elderly population. Several studies have highlighted an increased expression of senescence-related markers in the resident progenitor cells in COPD and IPF, possibly undermining epithelial integrity and contributing to the progression and the aggravation of both diseases. Recently, the chronic activation of the canonical Wnt/β-catenin pathway was shown to induce cellular senescence. Here, we investigated the localization and the expression of leucin-rich repeat-containing G-protein-coupled receptor 6 (LGR6), a protein that activates and potentiates the canonical Wnt signalling. Through immunohistochemical analyses, we identified a lesion-associated rise in LGR6 levels in abnormal lung epithelial progenitors in COPD and IPF when compared to histologically normal tissues. Moreover, in areas of aberrant regeneration, chronic damage and fibrosis, LGR6-expressing epithelial progenitors displayed a major increase in the expression of senescence-associated markers. Our study suggests the involvement of LGR6 in the chronic activation of the Wnt/β-catenin pathway, mediating the impairment and exhaustion of epithelial progenitors in COPD and IPF.
Open AccessIncreased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases
Chronic lung diseases (CLDs) represent a set of disorders characterized by the progressive loss of proper lung function. Among severe CLDs, the incidence of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) has grown over the last decades, mainly in the elderly population. Several studies have highlighted an increased expression of senescence-related markers in the resident progenitor cells in COPD and IPF, possibly undermining epithelial integrity and contributing to the progression and the aggravation of both diseases. Recently, the chronic activation of the canonical Wnt/β-catenin pathway was shown to induce cellular senescence. Here, we investigated the localization and the expression of leucin-rich repeat-containing G-protein-coupled receptor 6 (LGR6), a protein that activates and potentiates the canonical Wnt signalling. Through immunohistochemical analyses, we identified a lesion-associated rise in LGR6 levels in abnormal lung epithelial progenitors in COPD and IPF when compared to histologically normal tissues. Moreover, in areas of aberrant regeneration, chronic damage and fibrosis, LGR6-expressing epithelial progenitors displayed a major increase in the expression of senescence-associated markers. Our study suggests the involvement of LGR6 in the chronic activation of the Wnt/β-catenin pathway, mediating the impairment and exhaustion of epithelial progenitors in COPD and IPF.
- 1 November 2021
- Published by Elsevier in Cancer Letters
- Vol. 520, 57-67
PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition
- 1 November 2021
- Published by Elsevier in Cancer Letters
- Vol. 520, 57-67
PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition
- Open Access
- 1 January 2019
- Published by Sciaccess Publishers LLC in Journal of Lung Health and Diseases
- Vol. 3 (1) , 12-15
Lgr6: From Stemness to Cancer Progression
Lung cancer is the leading cause of cancer-related deaths worldwide with poor prognosis, mainly due to the delay in the diagnosis
- 1 January 2019
- Published by Sciaccess Publishers LLC in Journal of Lung Health and Diseases
- Vol. 3 (1) , 12-15
Open AccessLgr6: From Stemness to Cancer Progression
Lung cancer is the leading cause of cancer-related deaths worldwide with poor prognosis, mainly due to the delay in the diagnosis
- Open Access
- 2 November 2017
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (11) , e3164
RNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
Hepatic progenitor cells (HPCs) are small cells with a relative large oval nucleus and a scanty cytoplasm situated in the canals of Hering that express markers of (immature) hepatocytes and cholangiocytes. HPCs are present in large numbers in alcoholic steatohepatitis (ASH), one of the leading causes of chronic liver disease. To date, the mechanisms responsible for proliferation and differentiation of human HPCs are still poorly understood and the role of HPCs in ASH development is unknown. In this study, we aimed to characterise human HPCs and their interactions with other cells through comparison, on both protein and RNA level, of HPC-enriched cell populations from adult human liver tissue using different isolation methods. Fresh human liver tissue was collected from ASH explant livers and HPC-enriched cell populations were obtained via four different isolation methods: side population (SP), epithelial cell adhesion molecule (EpCAM) and trophoblast antigen 2 (TROP-2) membrane marker isolation and laser capture microdissection. Gene expression profiles of fluorescent-activated cell-sorted HPCs, whole liver extracts and laser microdissected HPC niches were determined by RNA-sequencing. Immunohistochemical evaluation of the isolated populations indicated the enrichment of HPCs in the SP, EpCAM+and TROP-2+cell populations. Pathway analysis of the transcription profiles of human HPCs showed an enrichment and activation of known HPC pathways like Wnt/β-catenin, TWEAK and HGF. Integration of the HPC niche profile suggests autocrine signalling by HPCs (TNFα, PDGFB and VEGFA) as well as paracrine signalling from the surrounding niche cells including MIF and IGF-1. In addition, we identified IL-17 A signalling as a potentially novel pathway in HPC biology. In conclusion, we provide the first RNA-seq-based, comparative transcriptome analysis of isolated human HPCs from ASH patients and revealed active signalling between HPCs and their surrounding niche cells in ASH livers and suggest that HPCs can actively contribute to liver inflammation.
- 2 November 2017
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (11) , e3164
Open AccessRNA-sequencing-based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers
Hepatic progenitor cells (HPCs) are small cells with a relative large oval nucleus and a scanty cytoplasm situated in the canals of Hering that express markers of (immature) hepatocytes and cholangiocytes. HPCs are present in large numbers in alcoholic steatohepatitis (ASH), one of the leading causes of chronic liver disease. To date, the mechanisms responsible for proliferation and differentiation of human HPCs are still poorly understood and the role of HPCs in ASH development is unknown. In this study, we aimed to characterise human HPCs and their interactions with other cells through comparison, on both protein and RNA level, of HPC-enriched cell populations from adult human liver tissue using different isolation methods. Fresh human liver tissue was collected from ASH explant livers and HPC-enriched cell populations were obtained via four different isolation methods: side population (SP), epithelial cell adhesion molecule (EpCAM) and trophoblast antigen 2 (TROP-2) membrane marker isolation and laser capture microdissection. Gene expression profiles of fluorescent-activated cell-sorted HPCs, whole liver extracts and laser microdissected HPC niches were determined by RNA-sequencing. Immunohistochemical evaluation of the isolated populations indicated the enrichment of HPCs in the SP, EpCAM+and TROP-2+cell populations. Pathway analysis of the transcription profiles of human HPCs showed an enrichment and activation of known HPC pathways like Wnt/β-catenin, TWEAK and HGF. Integration of the HPC niche profile suggests autocrine signalling by HPCs (TNFα, PDGFB and VEGFA) as well as paracrine signalling from the surrounding niche cells including MIF and IGF-1. In addition, we identified IL-17 A signalling as a potentially novel pathway in HPC biology. In conclusion, we provide the first RNA-seq-based, comparative transcriptome analysis of isolated human HPCs from ASH patients and revealed active signalling between HPCs and their surrounding niche cells in ASH livers and suggest that HPCs can actively contribute to liver inflammation.
- 1 January 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (1) , E85-E86
Could Sox2 be a useful target to treat lung squamous cell carcinoma?
Could Sox2 be a useful target to treat lung squamous cell carcinoma?
- 1 January 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (1) , E85-E86
Could Sox2 be a useful target to treat lung squamous cell carcinoma?
Could Sox2 be a useful target to treat lung squamous cell carcinoma?
- Open Access
- 30 June 2016
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (13) , 4012-4022
miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression
Defining the molecular and cellular roots of lung cancer relapse after initial treatment remains an imperative to improve survival. Here we report that the lung stem cell marker Lgr6 becomes enriched in non–small cell lung cancer (NSCLC) cells during malignant progression. Lgr6+ NSCLC cells displayed self-renewal and differentiation properties along with a higher tumorigenic potential. Mechanistic investigations suggested that a defective repression of the miR-17-92 gene cluster was responsible for evolution of a selection for outgrowth of Lgr6+ NSCLC cells. High levels of expression of miR-19 family members were found to target and downregulate levels of p38α kinase, providing a specific survival signal for Lgr6+ cells as mediated by increased Wnt/ß-catenin activity. Our results identify a specific stem-like cell population in NSCLC with increased malignant potential, the elucidation of which may enable earlier prognosis and possibly the development of more effective targeted treatments. Cancer Res; 76(13); 4012–22. ©2016 AACR.
- 30 June 2016
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (13) , 4012-4022
Open AccessmiR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression
Defining the molecular and cellular roots of lung cancer relapse after initial treatment remains an imperative to improve survival. Here we report that the lung stem cell marker Lgr6 becomes enriched in non–small cell lung cancer (NSCLC) cells during malignant progression. Lgr6+ NSCLC cells displayed self-renewal and differentiation properties along with a higher tumorigenic potential. Mechanistic investigations suggested that a defective repression of the miR-17-92 gene cluster was responsible for evolution of a selection for outgrowth of Lgr6+ NSCLC cells. High levels of expression of miR-19 family members were found to target and downregulate levels of p38α kinase, providing a specific survival signal for Lgr6+ cells as mediated by increased Wnt/ß-catenin activity. Our results identify a specific stem-like cell population in NSCLC with increased malignant potential, the elucidation of which may enable earlier prognosis and possibly the development of more effective targeted treatments. Cancer Res; 76(13); 4012–22. ©2016 AACR.
- Open Access
- 7 June 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (29) , 45060-45078
C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms
C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms
- 7 June 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (29) , 45060-45078
Open AccessC3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms
C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms
- Open Access
- 16 January 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3175
A paracrine network regulates the cross-talk between human lung stem cells and the stroma
The signals that regulate stem cell self-renewal and differentiation in the lung remain elusive. Lung stem cells undergo self-renewal or lineage commitment to replenish tissue, depending on cross-talk with their environment. This environment, also known as the niche, includes mesenchymal and endothelial tissues. Here we define molecular mechanisms involved in the interaction between human lung Lgr6+ stem cells (LSCs) and fibroblasts in a functional microenvironment. We reveal a central role for p38α MAPK in establishing and maintaining such cross-talk, acting in both cell types. In LSCs, p38α induces the expression of SDF-1, which activates the stroma. p38α is essential for fibroblast activation and induction of cytokine expression, in particular TNFα. This paracrine network induces a hierarchical activation leading to the recruitment of endothelium, establishing a functional microenvironment. Disruption of this cross-talk abrogates proper LSC differentiation in vivo and may lead to lung dysfunction and disease.
- 16 January 2014
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3175
Open AccessA paracrine network regulates the cross-talk between human lung stem cells and the stroma
The signals that regulate stem cell self-renewal and differentiation in the lung remain elusive. Lung stem cells undergo self-renewal or lineage commitment to replenish tissue, depending on cross-talk with their environment. This environment, also known as the niche, includes mesenchymal and endothelial tissues. Here we define molecular mechanisms involved in the interaction between human lung Lgr6+ stem cells (LSCs) and fibroblasts in a functional microenvironment. We reveal a central role for p38α MAPK in establishing and maintaining such cross-talk, acting in both cell types. In LSCs, p38α induces the expression of SDF-1, which activates the stroma. p38α is essential for fibroblast activation and induction of cytokine expression, in particular TNFα. This paracrine network induces a hierarchical activation leading to the recruitment of endothelium, establishing a functional microenvironment. Disruption of this cross-talk abrogates proper LSC differentiation in vivo and may lead to lung dysfunction and disease.